EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review

Frank Eric Tatsing Foka, Hazel Tumelo Mufhandu iD

Viruses · 13.08.2023 · 15 (8) · 1732

DOI: 10.3390/v15081732 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Viruses, online erschienen am 13.08.2023. Verfasst von Frank Eric Tatsing Foka und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Virology Laboratory, School of Biological Sciences, Faculty of Natural and Agricultural Sciences, North West University, …. Hauptthemen laut MEDLINE: Acquired Immunodeficiency Syndrome, HIV Infections. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiretroviral therapies (ARTs) have revolutionized the management of human immunodeficiency virus (HIV) infection, significantly improved patient outcomes, and reduced the mortality rate and incidence of acquired immunodeficiency syndrome (AIDS). However, despite the remarkable efficacy of ART, virologic failure remains a challenge in the long-term management of HIV-infected individuals. Virologic failure refers to the persistent detectable viral load in patients receiving ART, indicating an incomplete suppression of HIV replication. It can occur due to various factors, including poor medication adherence, drug resistance, suboptimal drug concentrations, drug interactions, and viral factors such as the emergence of drug-resistant strains. In recent years, extensive efforts have been made to understand and address virologic failure in order to optimize treatment outcomes. Strategies to prevent and manage virologic failure include improving treatment adherence through patient education, counselling, and supportive interventions. In addition, the regular monitoring of viral load and resistance testing enables the early detection of treatment failure and facilitates timely adjustments in ART regimens. Thus, the development of novel antiretroviral agents with improved potency, tolerability, and resistance profiles offers new options for patients experiencing virologic failure. However, new treatment options would also face virologic failure if not managed appropriately. A solution to virologic failure requires a comprehensive approach that combines individualized patient care, robust monitoring, and access to a range of antiretroviral drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acquired Immunodeficiency SyndromeHIV InfectionsHumansAnti-Retroviral AgentsMedication AdherenceTreatment Failure

Stichwörter der Autor:innen

AIDSHIVantiretroviral therapydrug resistancevirologic failure

Substanzen

Anti-Retroviral Agents

Autor:innen und Institutionen

  • Department of Microbiology, Virology Laboratory, School of Biological Sciences, Faculty of Natural and Agricultural Sciences, North West University, Mafikeng, Private Bag, Mmabatho X2046, South Africa.

ORCID-Profile: Hazel Tumelo Mufhandu

Zitieren

APA

Foka, F. E. T., & Mufhandu, H. T. (2023). Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review. Viruses, 15(8), 1732. https://doi.org/10.3390/v15081732

Vancouver

Foka FET, Mufhandu HT. Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review. Viruses. 2023;15(8):1732. doi:10.3390/v15081732

BibTeX
@article{Foka2023,
  author = {Foka, Frank Eric Tatsing and Mufhandu, Hazel Tumelo},
  title = {Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review},
  journal = {Viruses},
  year = {2023},
  volume = {15},
  number = {8},
  pages = {1732},
  doi = {10.3390/v15081732}
}
Kostenlos starten →